Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10057452 | 0.90 | KMT2A (0.42) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL8984601 | 0.88 | MEN1 (0.63) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL30009193 | 0.88 | MEN1 (0.63) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL19312967 | 0.84 | LMNA (0.59) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL30805724 | 0.84 | MEN1 (0.52) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL14190761 | 0.84 | MEN1 (0.52) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL11451560 | 0.81 | ELANE (0.44) | KMT2AMEN1MAPTELANETDP1 | |
| SCHEMBL11452303 | 0.81 | ELANE (0.44) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL4387188 | 0.81 | MEN1 (0.78) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL30289963 | 0.81 | MEN1 (0.54) | KMT2AMEN1MAPTLMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242705-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AJINOMOTO CO., INC. (JP) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242705-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AFF4, AFF1, AFF2 | KMT2A 322/4885MEN1 4381/4885MAPT 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.